For international companies
I want to enter the UAE market
For manufacturers, brand owners and healthcare innovators preparing a product or portfolio for the UAE.
- Assess
- Register
- Access
- Launch
- Maintain
Request quote 
UAE market entry & lifecycle support
Enter the UAE.Stay compliant. Grow with confidence.
ViaFarma helps international manufacturers enter the UAE and supports established healthcare companies with regulatory affairs, product registration, market access and lifecycle compliance.
Regulatory clarity Regional insight Commercial thinking
Registration
Compliance
Coding & coverage
Launch readiness
Market access
Partner match
One connected path. Every critical step.
From first assessment to lifecycle compliance.
Start from where you are
Two starting points. One connected UAE pathway.
Choose the route that reflects your current position. We then shape the scope around the product, evidence, ownership model and commercial objective.
For UAE-based companies
I already operate in the UAE
For MAHs, distributors, medical warehouses and healthcare teams managing approved products, portfolios and market-access challenges.
- Maintain
- Resolve
- Optimize
- Expand
Not sure which pathway applies?Start with a regulatory and commercial readiness assessment before committing resources.
Is your product ready for the UAE — beyond registration?
Free UAE Market-Entry Quick Check
Planning to introduce a pharmaceutical, medical device, healthcare or cosmetic product in the UAE? Send us your product and current approval status. The initial review can cover classification and pathway, regulatory readiness, obvious dossier gaps, market-entry considerations and a recommended next step. It is not a complete market-access assessment.
Send Product for Quick Check Book a 15-Minute ConsultationWe will review the information you send to identify the most appropriate first step.
Solutions by business objective
Specialist services connected around the outcome you need.
We do not start with a registration form. We start by understanding the product, its classification, evidence, ownership model and commercial objective.
01
Enter the UAE market
Build the right regulatory and commercial pathway before shipment, submission or partner commitment.
02
Maintain regulatory compliance
Keep approved products, dossiers and safety obligations aligned throughout the product lifecycle.
03
Access and grow the market
Connect regulatory approval with access, coverage, portfolio decisions and the right commercial relationships.
04
Strengthen local operations
Support UAE teams with specialist supply, capability, communication and business-development services.
Who we are
Local insight.
International standards.
Founded in Abu Dhabi in 2021, ViaFarma is a UAE-based pharmaceutical consultancy built for companies navigating complex, fast-moving healthcare markets.
Our multidisciplinary approach unites regulatory affairs, commercial strategy, medical communication and operational support—so your next step is always connected to the bigger goal.
View founder profileEmpowering pharma growth through compliance, creativity and connection.
We help clients turn regulatory complexity into sustainable commercial progress.
Integrity
Honest, transparent and professional partnership.
Excellence
High standards from strategy through execution.
Innovation
Modern solutions shaped around market needs.
Accountability
Clear ownership, disciplined delivery and results.
The ViaFarma market-entry journey
UAE market entry goes beyond registration.
Regulatory approval is an essential milestone — but successful UAE market entry also requires early planning for pricing and access, distribution and import readiness, launch execution and post-approval compliance.
Registration enables market entry. Access and execution determine what happens next. ViaFarma connects initial feasibility and registration with market-access readiness, launch planning and lifecycle management.
01
Assess
- Product classification and UAE regulatory feasibility
- Dossier and readiness assessment
- Preliminary market-entry considerations
- Regulatory and commercial pathway
02
Register
- Regulatory strategy and MAH/site requirements
- Dossier, eCTD and documentation support
- Artwork and labelling
- Authority queries and follow-up
03
Access
- Pricing pathway considerations
- Coding, coverage and insurance readiness
- Tender or procurement considerations where relevant
- Distributor and market-entry structure
04
Launch
- Import readiness and distributor coordination
- Launch regulatory readiness
- Promotional compliance where applicable
- Commercial and business-development support
05
Maintain
- Pharmacovigilance and post-market support
- Variations, renewals and labelling changes
- Ongoing regulatory compliance
- Lifecycle and market-access support
Why ViaFarma
A regional ally, not just a service provider.
End-to-end ownership
One partner from registration and training to brand, sourcing and export support.
Deep regulatory context
Specialized knowledge of pharmaceutical, nutraceutical and medical device pathways.
Commercially grounded
Advice shaped by feasibility, cost, timing and real market opportunity.
Strategic partner matching
A structured route from product opportunity to the right market partner.
Introductions are based on product fit, regulatory readiness and the strategic plan—not on a generic contact list.
Assess
Review the product, evidence, ownership model and commercial objective.
Plan
Define the regulatory route, target market and realistic partner profile.
Match
Identify and shortlist suitable distributors, agents or commercial partners.
Connect
Make the introduction and support the next regulatory and commercial steps.
Selected problem-solving experience
Clear thinking when regulatory and commercial paths become difficult.
These anonymized examples are drawn from professional regulatory and market-access experience. Client and product identities remain confidential.
Turning four submissions from technical issues to VALID
Challenge
Four UAE eCTD dossiers required structural, content and validation corrections before they could progress.
Approach
The dossier structures and findings were reviewed, corrections were coordinated and the final sequences were verified.
Outcome
All four submissions were confirmed VALID and ready to proceed for authority review.
Clarifying the route to unlock a DOH application
Challenge
A healthcare product was stalled because it was unclear whether additional federal registration was required first.
Approach
The intended use, category and supporting product information were assessed against the applicable pathway.
Outcome
The clarification enabled the project to move forward to the appropriate DOH application stage.
A go/no-go review that prevented an unviable launch
Challenge
A product opportunity faced strong competition, limited insurance coverage and realistic demand below the required commitment.
Approach
Classification, access conditions, competition, demand and commercial assumptions were reassessed together.
Outcome
A clear no-go recommendation avoided unnecessary registration, listing and launch investment.
Clear answers
Frequently asked questions about ViaFarma.
Direct information to help companies identify the right pathway and next step.
What pharmaceutical consulting services does ViaFarma provide?
ViaFarma supports regulatory strategy, product registration, eCTD and technical files, pharmacovigilance, medical content, training, market access, insurance problem solving, product representation and strategic partner matching.
Which markets and authorities does ViaFarma work with?
ViaFarma is based in Abu Dhabi and supports projects across the UAE, GCC and Jordan, including pathways involving EDE, MOHAP, MOIAT, Dubai Municipality, DOH, DHA and JFDA.
Can ViaFarma help with DOH and DHA coding or insurance coverage barriers?
Yes. ViaFarma helps assess coding requirements, coordinate with relevant stakeholders and solve practical coverage, claims and market-access barriers in Abu Dhabi, Dubai and other emirates.
Can ViaFarma connect a product owner with a UAE distributor or commercial partner?
Yes. ViaFarma first reviews the product, evidence, market opportunity and strategic plan, then identifies and facilitates discussions with a suitable distributor, agent or commercial partner.
Is UAE product registration enough to launch a pharmaceutical product?
Registration is essential, but a launch also depends on matters such as pricing and access readiness, coding or coverage where relevant, distribution, import planning, compliant promotion and post-approval obligations.
What should companies plan for after regulatory approval in the UAE?
Companies should prepare for import and supply arrangements, distributor coordination, applicable pricing, coding, coverage or procurement pathways, launch compliance, pharmacovigilance, variations and renewals.
When should market-access planning begin for a UAE launch?
It should begin early enough to identify pricing, coding, coverage, procurement, distributor and evidence considerations before they delay or weaken the launch plan.
How are registration, pricing, coverage, distribution and launch connected?
They are separate but interdependent workstreams. Early coordination helps align the regulatory pathway, commercial model, access requirements, import structure and launch sequence without implying a guaranteed outcome.
How can a company start working with ViaFarma?
Book a free 15-minute consultation or contact the team by email or WhatsApp. ViaFarma will clarify the immediate need, required information and practical next step.
Start a conversation
What is your next pharma milestone?
Tell us where you need clarity. We will help define the practical path forward.